RV
RVL Pharmaceuticals plc
RVLPQ · OTC
$0.00 +0.00% (+$0.00)
Market Cap $1.11K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Moderate
4/9Valuation
100 /100
Cheap P/B 0.00x
P/S 0.00x
EV/FFO N/A
Growth
0 /100
Declining Book val. growth 23.63%
Rev. growth 40.83%
FCF growth N/A
Profitability
20 /100
Weak Op. margin 91.87%
Gross margin 80.98%
FCF margin 77.56%
Quality
7 /100
Poor Asset turnover 0.39x
ROIC 41.26%
ROA 40.22%
Debt
64 /100
Moderate Int. coverage -15.63x
Debt/Equity 1.13x
Net debt/EBITDA -0.36x
Stability
22 /100
Unstable EPS volatility 28.09%
Beta 8.91x
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na RVLPQ
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Brian A. Markison
Employees
125
Headquarters
Bridgewater
Nadcházející události
13 LIS
Earnings
Upcoming earnings report